Megan Turley, MD
Colon & Rectal Surgery · Austin, TXNPI 1639598402
Payments from drug & device makers
What this record shows
This record is dominated by education: $13,150 of the $20,660 with a category attached, or 63.7%. Intuitive Surgical accounts for 86.1% of it on its own, with 12 other manufacturers making up the rest.
Across 69 payments — averaging $299.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$18K
- Medtronic$1K
- Pfizer$1K
- THD America, Inc.$297
- Penumbra, Inc.$100
- Integra Lifesciences Corporation$43
- plus $173 from 7 others
What the payments were for
- Speaking & faculty fees$1,0005%
- Travel & lodging$3,41217%
- Food & beverage$3,07115%
- Education$13,15064%
- Gifts$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 41 | $17,795 |
| Medtronic | 13 | $1,196 |
| Pfizer | 2 | $1,056 |
| THD America, Inc. | 3 | $297 |
| Penumbra, Inc. | 1 | $100 |
| Integra Lifesciences Corporation | 2 | $43 |
| Hologic Sales And Service, LLC | 1 | $36 |
| Innovation Technologies Inc | 1 | $30 |
| Dilon Technologies, Inc. | 1 | $28 |
| Tempus AI, Inc | 1 | $23 |
| TELA Bio, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Coloplast | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$9,000
- Da Vinci Surgical System$8,045
- BRAFTOVI$1,000
- INTERSTIM$582
- INTELLIS ADAPTIVESTIM$156
- Indigo System$100
How this compares
$20,660 in reported general payments places this provider in the 80th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 32 | $149 |
| Gabapentin | 22 | $78 |
| Methocarbamol | 13 | $60 |
| Tramadol Hcl | 27 | $50 |
| Metronidazole | 32 | $28 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Austin
- Thiru LakshmanAustin$756K
- Amar ShahAustin$51K
- Andrew MillerAustin$41K
- Ricardo SolisAustin$15K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
- Farshid AraghizadehFort Worth$181K
- Jefferson HurleyIrving$163K
- Erik AskenasyHouston$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.